n = 67 | |
---|---|
Sites and types of infections, n (%) | |
- Respiratory tract | 30 (45%) |
- Herpes zoster | 16 (24%) |
- Gastrointestinal tract | 6 (9%) |
- Bacteremia | 6 (9%) |
- Urinary tract | 6 (9%) |
- ABSSI | 2 (3%) |
- Other | 1 (2%) |
Type of treatment at infection, n (%) | |
- Induction | 29 (43%) |
- Maintenance | 36 (54%) |
- No treatment | 2 (3%) |
Prednisone dose at the time of infection, median (range) | 19 (5–30) mg/day |